Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT00528034
Eligibility Criteria:
Inclusion Criteria:
* Patients must have invasive vaginal cancer, any histology, any stage.
* Patients with prior excision of the primary are eligible.
* Patients with recurrent vaginal cancer who have not had a prior inguinal or groin lymph node dissection.
* Patients undergoing either surgical resection and assessment of inguinal or groin lymph nodes, radiation therapy and/or chemotherapy.
* Patients must sign an IRB approved informed consent.
Exclusion Criteria:
* Known allergy to triphenylmethane compounds.
* Pregnancy.
* Prior radiation therapy to the vagina, vulva, groin or pelvis.
* Prior inguinal, femoral or pelvic lymphadenectomy.
* Patients who are not good surgical candidates.
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT00528034
Study Brief:
Protocol Section:
NCT00528034